中國人壽(2628.HK)高開2% 前三季度淨利大增190.4%
格隆匯10月30日丨中國人壽(2628.HK)高開2.08%,報20.15港元,盤前成交6044萬港元,最新總市值8636億港元;A股高開1.59%,報31.36元。

昨晚中國人壽公佈財報顯示,前三季度中國人壽歸屬於母公司股東的淨利潤577.02億元,同比增190.4%。
對於中國人壽利潤大增的原因,有分析師認為,主要是投資管理體系深化改革成效顯著,固收類投資及權益類投資收益均大幅增長。
中金最新報告稱,中國人壽第三季度新業務價值同比增速大幅超過市場預期,並繼續領跑行業,上調今年盈利預測21%。第三季度淨利潤強勁增長,主要受益於投資收益大幅改善、税收政策變化,及去年同期基數較低。預計公司將在今年下半年和明年保持領先同業的強勁增長,這將有助於扭轉市場對於公司高增長持續性的質疑,推動估值修復。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.